Acceleron Pharma Adds Francois Nader To Board - Quick Facts

(RTTNews) - Acceleron Pharma Inc. (XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, Friday announced the appointment of Francois Nader, M.D., M.B.A, to its Board of Directors.

Nader is a 30-year veteran of the healthcare industry. He has been President, Chief Executive Officer and a member of the Board of Directors of NPS Pharma since 2008. During his tenure, Nader transformed NPS Pharma into a leading global rare disease company.

He joined NPS Pharma in 2006 as chief medical and commercial officer and was promoted to chief operating officer in 2007. Previously, he was a venture partner at Care Capital.